Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: Bone Resorption, Osteoclastogenesis and Adalimumab [NA]

View source ↗

Summary

Completed clinical trial investigating bone resorption and osteoclastogenesis in rheumatoid arthritis patients treated with adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED